Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients

<div>Timeline of disease course according to days from initial presentation of illness and days from hospital admission, from February 16 to March 7, 2020. SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.</div>

Canadian Journal of Infectious Diseases and Medical Microbiology

tab5

Table 5

Table 5: Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients 